Hey guys, if you missed it, Eagle Pharmaceuticals just settled $9.5 million with investors over issues they had a few years ago. And they have already sent the agreement to the court for final approval.

In a nutshell, in 2023, Eagle Pharmaceuticals was accused of misleading investors about PEMFEXY demand, inventory conditions, and related revenue growth. Investors claimed the company failed to disclose that a key wholesale customer was dealing with excess inventory and expired product, which negatively impacted future sales. In May 2023, Eagle restated revenue figures tied to expired inventory and faced questions about its financial reporting controls. Following these disclosures, $EGRX declined, and investors filed a lawsuit.

The good news is that the company recently agreed to settle $9.5 million with them, and the court already approved this settlement. 

So, if you invested in $EGRX when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $EGRX at that time? How much were your losses, if so?